Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
02359 WUXI APPTEC
RTNominal up37.100 +0.250 (+0.678%)
Others

06/11/2019 16:56

WuXi AppTec (02359) assigned "BBB-" rating; outlook stable

[ET Net News Agency, 6 November 2019] S&P Global Ratings assigned its "BBB-" long-term
issuer credit rating to WuXi AppTec Co. Ltd. (02359).
The stable outlook reflects the credit rating agency's expectation that WuXi AppTec will
continue to increase revenue at 25%-30% annually and that the EBITDA margin will moderate
over the next 24 months.
WuXi AppTec is the leading contract research organization (CRO) in China and among the
world's top-10 CROs for pharma firms. The company benefits from cost advantages and should
enjoy a high growth rate over the next several years while maintaining modest leverage.
The company's smaller scale and less extensive offering in clinical CRO partly temper
these advantages. (KL)

Remark: Real time quote last updated: 28/03/2024 18:00
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.